Related Experiment Video
Updated: Jun 26, 2026
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
[Chronic thromboembolic pulmonary hypertension].
1Université Paris-Descartes, faculté de médecine, service de pneumologie et soins intensifs, Hôpital européen Georges-Pompidou, AP-HP, 75908 Paris Cedex 15, France. olivier.sanchez@egp.aphp.fr
La Revue Du Praticien
|January 16, 2009
Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) involves persistent clots and vessel remodeling, leading to right heart failure. Pulmonary endarterectomy is the primary treatment, with antiproliferative therapies for severe or inoperable cases.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Context:
- Chronic thromboembolic pulmonary hypertension (CTEPH) arises from unresolved blood clots in pulmonary arteries.
- This condition leads to pulmonary vascular remodeling and increased resistance.
- Progressive right heart failure is a common consequence of untreated CTEPH.
Purpose:
- To outline the diagnostic criteria for CTEPH.
- To detail the recommended treatment strategies for CTEPH.
- To discuss alternative therapies for severe or inoperable CTEPH cases.
Summary:
- CTEPH is defined by persistent obstructive thromboemboli and pulmonary vascular remodeling.
- Diagnosis involves echocardiography, right heart catheterization, and ventilation-perfusion lung scans.
- Spiral CT and pulmonary angiography are crucial for assessing surgical candidacy.
Impact:
- Pulmonary endarterectomy is the preferred treatment for operable CTEPH patients.
- Antiproliferative treatments offer alternatives for severe or inoperable cases.
- Effective management of CTEPH improves outcomes and reduces right heart failure progression.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...